Bioavailability and Satiety Study of a Cretan Carob Beverage
Study Details
Study Description
Brief Summary
This is an interventional, open-label, single-group, bioavailability and satiety postprandial crossover study. The aim of the study is to evaluate the bioavailability of active compounds of a beverage prepared with Cretan carob powder, as well as the subjective and objective satiety in healthy individuals after its consumption.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
This is an interventional, open-label, single-group, bioavailability and satiety postprandial crossover study. The aim of the study is to evaluate the bioavailability of active constituents of a beverage with carob powder and of the subjective and objective satiety of healthy individuals after its consumption. Twenty apparently healthy male and female adults of normal Body-Mass Index will be enrolled based on certain inclusion and exclusion criteria. After enrollment, the volunteers will undergo a medical and dietary assessment and will be instructed to follow a low-phytochemical diet (washout) for five consecutive days, excluding from their diet sources of phytochemicals, i.e., fruits, vegetables, legumes, coffee, tea. Compliance with the low-phytochemical diet will be assessed with a 24 h recall during and at the end of the washout period. On the day of the experiment and in a crossover design following washout, volunteers will be given either a sucrose beverage or a carob beverage before consuming a standard meal. Blood samples will be collected 0.5, 1.0, 1.5, 2.0, 2.5 and 3.0 h postprandially and isolated serum and plasma samples in all time intervals will be used for the measurement of ghrelin levels as a marker of objective satiety and for LC-ESI-MS/MS approach in order (a) to identify putative polyphenol metabolites related to carob consumption and (b) to investigate the associations of the metabolic profile of the volunteers to the appetite modulation and satiety. Also, volunteers will self-assess appetite parameters using the visual analog scale (VAS) in all time points postprandially. Additionally, objective satiety will be measured through the next food intake; participants will consume a weighed snack that will be administered ad libitum 3h after the meal consumption. Food intake will be calculated by weighting the amount of snack food remaining after consumption.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Carob beverage
|
Other: Carob beverage
Volunteers will consume 2 tablespoons of carob powder in 200mL drinking water.
|
Other: Sucrose beverage
|
Other: Sucrose beverage
Volunteers will consume a beverage with sucrose equal to this contained in carob beverage (approx. 5g) prepared in 200mL drinking water.
|
Outcome Measures
Primary Outcome Measures
- Changes in VAS scale [Three hours]
Changes in VAS scale for the comparison of subjective satiety between the two groups
Secondary Outcome Measures
- Differences in the weight of food remaining after consumption. [Three hours]
Differences in the quantity of food remaining after consumption for the comparison of objective satiety between the two groups.
- Changes in plasma ghrelin [Three hours]
Changes in plasma ghrelin for the comparison of objective satiety between the two groups.
- Identification of putative polyphenol metabolites related to carob consumption. [Three hours]
Polyphenol metabolites related to carob consumption will be identified using LC-ESI-MS/MS.
- Investigation of the associations of the metabolic profile of the volunteers to the appetite modulation and satiety. [Three hours]
Metabolic profile of the volunteers as assessed by LC-ESI-MS/MS will be evaluated for potential associations with appetite modulation and satiety.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
healthy males and females adults
-
normal weight
Exclusion Criteria:
-
overweight/obesity (BMI>25kg/m2)
-
Type 1 Diabetes, cardiovascular diseases, hypertension
-
thyroid disorder, liver disease, kidney disease
-
gastrointestinal disease
-
pregnant or lactating women
-
mental illness
-
use of nutraceutical supplements or natural products for weight loss
-
dietitians/nutritionists
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Harokopio University
Investigators
- Principal Investigator: Andriana C Kaliora, Harokopio University of Athens, Greece
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- CRETAN CAROB_147